These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6889513)

  • 21. [Acute toxicity of the N-acyl derivatives of carminomycin and rubomycin].
    Shepelevtsev NG; Gol'dberg LE; Olsuf'eva EN; Povarov LS
    Antibiotiki; 1982 Jan; 27(1):57-61. PubMed ID: 7059147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of carminomycin in combination with UHF hyperthermia in the therapy of sarcoma 180].
    Lopatin VF; Dedenkov AN; Vatin AE
    Antibiotiki; 1979 Aug; 24(8):619-22. PubMed ID: 485112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the toxicity of carminomycin 13-cyclohexylidenhydrazone].
    Shepelevtseva NG; Vertogradova TP; Belova IP; Gol'dberg LE
    Antibiotiki; 1983 Feb; 28(2):90-5. PubMed ID: 6838184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytostatic action of semisynthetic derivatives of carminomycin].
    Volkolupova OP; Makukho LV
    Antibiotiki; 1982 Feb; 27(2):145-7. PubMed ID: 7065650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs.
    Syrkin AB; Kiselev AV
    Oncology; 1980; 37 Suppl 1():67-70. PubMed ID: 6935578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I-II evaluation of carminomycin in adults with acute leukemia.
    Debusscher L; Malarme M; Bron D; Rozencweig M; Stryckmans P
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):31-4. PubMed ID: 3855751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the effects of carminomycin 13-cyclohexylidenehydrazone and carminomycin on several immunologic responses of the body].
    Malkova IV; Shapovalova SP
    Antibiotiki; 1984 May; 29(5):374-7. PubMed ID: 6378085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
    Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
    Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 30. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin].
    Povarov LS; Isaeva NN
    Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the antitumor, immunodepressive and toxic properties of carminomycin-albumin complexes differing in carminomycin content].
    Aleksander SK; Liashenko VA; Iakushkina IV
    Antibiotiki; 1981 Apr; 26(4):298-302. PubMed ID: 6894522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis and mass-spectrometric analysis of N-cycloalkyl derivatives of carminomycin, daunorubicin and their analogs].
    Olsuf'eva EN; Rozynov BV
    Bioorg Khim; 1990 Jun; 16(6):847-53. PubMed ID: 2222529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Aleksandrova LG; Rozynov BV; Potapova NP
    Antibiot Khimioter; 1988 Oct; 33(10):729-35. PubMed ID: 3214206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of phosphoramide mustard analogues of daunomycin and carminomycin.
    Csorvási A; Kövér KE; Menyhárt MM; Sztaricskai F; Dobrynin YV; Nikolaeva TG
    Arch Pharm (Weinheim); 1998 Sep; 331(9):265-8. PubMed ID: 9793480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the T- and B-lymphocyte ratio in bone sarcoma patients before and after carminomycin treatment].
    Vatin AE; Bizer VA
    Antibiotiki; 1980 Nov; 25(11):864-7. PubMed ID: 6969572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
    Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intensification of the cytostatic action of adriamycin and carminomycin by amphotericin B].
    Makukho LV; Volkolupova OP; Gauze GF
    Antibiotiki; 1980 Apr; 25(4):294-6. PubMed ID: 7369735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carminomycin in the therapy of leukemias].
    Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
    Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
    [No Abstract]   [Full Text] [Related]  

  • 40. One-electron reduction of an anthracycline antibiotic carminomycin by a human erythrocyte redox chain.
    Peskin AV; Bartosz G
    FEBS Lett; 1987 Jul; 219(1):212-4. PubMed ID: 3036597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.